SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: dollarone who wrote (2666)4/13/1999 10:08:00 AM
From: greg Benfield  Read Replies (1) | Respond to of 2887
 
You have a cost savings of $600K and possible greater exposure of existing product line that has been languishing. MRI picked this line for a reason. I think for two reasons to gain access to the manu. process that ABMI has patented. Secondly to make and sell ABMI products. Anyway I feel that this additional income in conjunction with reductions in overhead will create a better cash flow situation. Is that such a reach?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News